| Financial Year |
March 31 2023 |
| Monetary Funds |
872,485,782.42 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
48,148,146.45 |
| Accounts Receivable |
180,652,408.98 |
| Advances to Suppliers |
172,160,467.89 |
| Other Receivables |
35,470,299.28 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
473,028,482.72 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,104,195.41 |
| Total Current Assets |
3,249,712,426.27 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
110,496,964.81 |
| Investment Properties |
19,818,166.10 |
| Fixed Assetes |
167,957,547.68 |
| Under-construction Projects |
245,977,822.41 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
623,631,439.19 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
12,886,788.69 |
| Deferred Income Tax Assets |
147,981,162.06 |
| Other Non-Current Assets |
8,928,887.85 |
| Sub-Total of Non-Current Assets |
1,410,634,689.80 |
| Total Assets |
4,660,347,116.07 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
5,855,142.01 |
| Accounts Payable |
492,692,787.76 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
323,333,470.85 |
| Taxes Payable |
71,467,170.84 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
31,558,718.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
29,697,705.06 |
| Other Current Liabilities |
97,788,293.50 |
| Sub-Total of Current Liabilities |
2,327,533,630.19 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,982,088.40 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
40,406,838.09 |
| Total Liabilities |
2,367,940,468.28 |
| Paid-In Capital(Or Share Stock) |
400,010,000.00 |
| Capital Surplus |
857,613,745.96 |
| Surplus Reserve |
335,050,102.45 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
668,829,096.86 |
| Minority Stockholder's Interest |
30,903,702.52 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,261,502,945.27 |
| Owner's Equity（Stockholder's Equity） |
2,292,406,647.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,660,347,116.07 |
